September 11, 2008 - Royal Philips Electronics today said it has signed a memorandum of understanding (MOU) setting out ...
September 11, 2008 - Good Samaritan Hospital was among the first in the nation to implant a TELIGEN implantable cardioverter defibrillator (ICD) made by Boston Scientific.
September 11, 2008 - Advanced image-processing and 3D visualization solutions provider TeraRecon Inc. today released new ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
September 11, 2008 - The American College of Cardiology (ACC) has certified LUMEDX an ACC-NCDR CARE Registry software ...
September 11, 2008 -Cook Medical has completed enrollment in the first international clinical trial of a first-of-its-kind drug-eluting stent designed to treat arterial blockages outside the coronary arteries.
TeraRecon Inc. released new innovations in its flagship Aquarius iNtuition client-server to empower nuclear cardiologists to improve efficiency within their cardiac imaging portfolio.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
September, 10, 2008 - Members of the Venous Disease Coalition (VDC) and the Office of the Surgeon General will unite to ...
The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System. Boston Scientific ...
September 10, 2008 - CardioVascular BioTherapeutics Inc. announced yesterday that the first U.S. site is open for ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
September 9, 2008 - Ventricular assist device manufacturer MicroMed Cardiovascular Inc. today said it completed all ...
Pathway Medical Technologies Inc. offers the Jetstream, a peripheral atherectomy catheter designed for use in the treatment of peripheral artery disease (PAD) in the lower limbs. The device is capable of treating an entire spectrum of disease found in the PAD patient, including hard and soft plaque, calcium, thrombus and fibrotic lesions with consistent clinical results, the company said.
September 9, 2008 - CoreValve said today five clinical evaluation sites (two in New Zealand and three in Australia) have now completed their first series of proctored cases using the company’s proprietary ReValving System for percutaneous aortic valve replacement (PAVR), which features a porcine pericardium valve mounted in a self-expanding frame.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
September 9, 2008 - Lantheus Medical Imaging Inc. issued a statement assuring regulatory authorities, key customers and ...
September 9, 2008 - Celera Corp. and its collaborators at Brigham and Women’s Hospital today said a paper published in ...
September 8, 2008 - Toshiba Teli America Inc. said today it is shipping the T24MSA001-MD medical-grade 24-inch LCD color ...
September 10, 2008
